Rocket


Overview
Financials
News + Filings
Key Docs
Ownership


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
IM Cannabis Corp. (IMCC) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 6-K Quarterly results
10/10/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Company", "IMCannabis", or "IMC"
10/03/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Form 7 - Monthly Progress Report"
09/29/2023 6-K Quarterly results
08/14/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Company" or "IMC",
"IM CANNABIS CORP. AND ITS SUBSIDIARIES NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS",
"Review: I have reviewed the interim financial report and interim MD&A of IM Cannabis Corp. for the interim period ended June 30, 2023. 2. No misrepresentations: Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings. 3. Fair presentation: Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance...",
"Review: I have reviewed the interim financial report and interim MD&A of IM Cannabis Corp. for the interim period ended June 30, 2023. 2. No misrepresentations: Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings. 3. Fair presentation: Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance...",
"SCHEDULE A: FINANCIAL STATEMENTS Financial statements are required as follows: For the first, second and third financial quarters interim financial statements prepared in accordance with the requirements under Ontario securities law must be attached. If the Issuer is exempt from filing certain interim financial statements, give the date of the exempting order. FORM 5 – QUARTERLY LISTING STATEMENT January 2015 Page 1"
08/11/2023 6-K Quarterly results
08/08/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Company", "IMCannabis", or "IMC"
08/04/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, announced today that the Company received written notification from The Nasdaq Stock Market LLC ("Nasdaq"
08/02/2023 6-K Quarterly results
07/06/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Form 7 - Monthly Progress Report"
06/13/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, today announced that on June 12, 2023, it has received formal notice from The Nasdaq Stock Market, LLC stating that the Company has regained compliance with the minimum bid price requirement set forth in Rule 5550 of the Nasdaq Listing Rules (the “Minimum Bid Price Requirement"
05/19/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "Statement of Executive Compensation",
"Statement of Executive Compensation"
05/15/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Company" or "IMC",
": 6",
"IM Cannabis” or the “Company”) is a British Columbia company operating in the international medical cannabis industry. The Company’s common shares trade under the ticker symbol “IMCC” on both the NASDAQ Capital Market and the Canadian Securities Exchange (“CSE",
"Review: I have reviewed the interim financial report and interim MD&A of IM Cannabis Corp. for the interim period ended March 31, 2023. 2. No misrepresentations: Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings. 3. Fair presentation: Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performanc...",
"Review: : I have reviewed the interim financial report and interim MD&A of IM Cannabis Corp. for the interim period ended March 31, 2023. 2. No misrepresentations: Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings. 3. Fair presentation: Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performa..."
05/08/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Company" or "IMC") , an international medical cannabis company, is announcing that it has closed the previously announced securities for debt settlement transaction with L5 Capital Inc. , a company wholly-owned and controlled by Marc Lustig, the executive chairman and a director of the Company. Pursuant to the Debt Settlement, the Company settled outstanding indebtedness of $838,776 through issuing 492,492 units at a price of US$1.25 per Unit. Each Unit consists of one common share of the Company and one Common Share purchase warrant (each, a "Warrant",
"CERTIFICATE OF COMPLIANCE",
"Material Change Report",
"Common Shares”) and 492,492 Common Share purchase warrants of the Company on May 5, 2023. The Common Shares and Warrants were issued as disclosed in the Company’s press release and Form 9 – Notice of Proposed Issuance of Listed Securities",
"Common Shares”) of IM Cannabis Corp. (the “Issuer"
05/08/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Company", "IMCannabis", or "IMC"
05/03/2023 6-K Quarterly results
04/28/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Company" or "IMC") , an international medical cannabis company, has agreed to a securities for debt settlement transaction with L5 Capital Inc. , a company wholly-owned and controlled by Marc Lustig, the executive chairman and a director of the Company. Pursuant to the Debt Settlement, the Company will settle outstanding indebtedness of $838,776 through the issuance of 492,492 units at a price of US$1.25 per Unit. Each Unit consists of one common share of the Company and one Common Share purchase warrant (each, a “Warrant",
"Form 9 - Proposed Issuance of Securities"
04/14/2023 6-K Quarterly results
04/04/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Form 7 - Monthly Progress Report"
03/29/2023 6-K Quarterly results
03/17/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Material Change Report"
03/15/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Toronto, Ontario and Glil Yam, Israel - March 15, 2023 – IM Cannabis Corp. (the “Company” or “IMC"
03/08/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Toronto, Ontario and Glil Yam, Israel - March 8, 2023 – IM Cannabis Corp. (the “Company” or “IMC"
03/07/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Form 7 - Monthly Progress Report"
02/23/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Warrant Indenture",
"Material Change Report"
02/13/2023 6-K Quarterly results
02/09/2023 6-K Quarterly results
02/09/2023 6-K Quarterly results
02/07/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Form 7 - Monthly Progress Report"
02/02/2023 6-K Quarterly results
02/02/2023 6-K Quarterly results
01/26/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Material Change Report"
01/25/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Material Change Report"
01/23/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Toronto, Ontario and Glil Yam, Israel - January 20, 2023 – IM Cannabis Corp. , an international medical cannabis company, is pleased to announce that it has closed a second tranche of its previously announced non-brokered private placement offering of units of the Company . An aggregate of 757,172 Units were issued and sold for aggregate gross proceeds of US$946,465 pursuant to the second tranche of the Private Placement. Each Unit consisted of one common share of the Company and one Common Share purchase warrant (each a “Warrant"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy